iFabric Corp Updates on Clinical Trial for Treated Medical Scrubs
MARKHAM, ON / ACCESSWIRE / July 21, 2022 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today provides an update on its clinical trial of medical garments (i.e. "scrubs") treated with the Company's ProTX2 antimicrobial and …
Weiterlesen »